Home / Hepatitis B, Purified Antigen / Belgium
BE ATC J07BC01 · updated 2 Nov 2026
Hepatitis B, Purified Antigen shortage in Belgium
Is there a Hepatitis B, Purified Antigen shortage in Belgium?
Yes. As of 2 Nov 2026, 1 Hepatitis B, Purified Antigen product is reported short in Belgium, the first since 13 Oct 2026. The company estimate for the return is 21 Dec 2026. Main reason: manufacturing problem.
Also short in Italy, Switzerland. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Engerix B 20 µg/1 ml inj. susp. s.c./i.m. pre-filled syr. 1 dose (1 ml) | GlaxoSmithKline Biologicals | 13 Oct 2026 | 21 Dec 2026 | Manufacturing problem Delay in the release of the end product |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.